<p class="fL">
	   By continuing to use this site you consent to the use of cookies on your device as described in our 
	   <a href="/cookie-policy" target="_blank">Cookie Policy</a> unless you have disabled them. You can change your <a href="/cookie-setting" target="_blank">Cookie Settings</a> at any time but parts of our site will not function correctly without them. 
	   </p>
<p class="fL">
<span>
<a href="/author/search/keyword/capital-market" target="_blank">Capital Market</a> 								  								  								  							  </span>
<meta content="2014-03-13T11:27:00+05:30" itemprop="datePublished">
<span content="2014-03-13" itemprop="datePublished">							  Last Updated at March 13, 2014 23:55 IST</span>
</meta></p>
<p><a class="storyTags" href="/search?type=news&amp;q=sun+pharmaceutical" target="_blank">Sun Pharmaceutical </a>Industries lost 4.17% to Rs 578.80 at 11:21 <a class="storyTags" href="/search?type=news&amp;q=ist" target="_blank">IST </a>on BSE, on reports the USFDA has imposed an import alert on the company's plant in <a class="storyTags" href="/search?type=news&amp;q=gujarat" target="_blank">Gujarat.</a></p>
<p>
Meanwhile, the <a class="storyTags" href="/search?type=news&amp;q=bse" target="_blank">BSE </a>Sensex was up 83.19 points, or 0.38%, to 21,939.41
<script type="text/javascript">document.write("<!--");if(isUserBanner=="free"&&(displayConBanner==1))document.write("-->");</script><script>googletag.cmd.push(function(){googletag.defineOutOfPageSlot('/6516239/outofpage_1x1_desktop','div-gpt-ad-1490771277198-0').addService(googletag.pubads());googletag.pubads().enableSyncRendering();googletag.enableServices();});</script>
<div class="article-middle-banner" id="div-gpt-ad-1490771277198-0">
<script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1490771277198-0');});</script>
</div>
<script>var banHeight=$(".article-middle-banner iframe").height();if(banHeight<=1){$(".article-middle-banner").height(0);$(".article-middle-banner").next().next().remove();}</script><!-- INPAGE_BANNER --><script>displayConBanner=1;</script><p>
On BSE, so far 3.74 lakh shares were traded in the counter, compared with an average volume of 1.40 lakh shares in the past one quarter.
</p><p>
The stock hit a high of Rs 610 and a low of Rs 565.60 so far during the day. The stock hit a record high of Rs 653.10 on 3 March 2014. The stock hit a 52-week low of Rs 405.50 on 1 April 2013.
</p><p>
The stock had underperformed the market over the past one month till 12 January 2014, falling 1.15% compared with the Sensex's 6.88% rise. The scrip, however, outperformed the market in past one quarter, gaining 4.98% as against Sensex's 4.45% rise.
</p><p>
The large-cap company has an equity capital of Rs 207.12 crore. Face value per share is Re 1. 
</p><p>
As per reports, the US Food and Drug Administration (USFDA) has imposed a ban on imports from <a class="storyTags" href="/search?type=news&amp;q=sun+pharmaceutical" target="_blank">Sun Pharmaceutical </a>Industries's plant at Karkhadi in <a class="storyTags" href="/search?type=news&amp;q=gujarat" target="_blank">Gujarat.</a> The Karkhadi plant makes both drug ingredients and formulations. The USFDA's "import alert" was announced on Wednesday, 12 March 2014. According to the FDA, an "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices. 
</p><p>
<a class="storyTags" href="/search?type=news&amp;q=sun+pharmaceutical" target="_blank">Sun Pharmaceutical </a>Industries' consolidated net profit surged 73.73% to Rs 1531.09 crore on 51.59% increase in total income to Rs 4446.82 crore in Q3 December 2013 over Q3 December 2012.
</p><p>
Sun Pharmaceutical Industries is an international specialty pharmaceutical company with over 72% sales from global markets. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in US, India and several other markets across the world.
</p><p><b><i>Powered by</i> Capital Market - Live News</b></p>
</p>
<p>
On BSE, so far 3.74 lakh shares were traded in the counter, compared with an average volume of 1.40 lakh shares in the past one quarter.
</p>
<p>
The stock hit a high of Rs 610 and a low of Rs 565.60 so far during the day. The stock hit a record high of Rs 653.10 on 3 March 2014. The stock hit a 52-week low of Rs 405.50 on 1 April 2013.
</p>
<p>
The stock had underperformed the market over the past one month till 12 January 2014, falling 1.15% compared with the Sensex's 6.88% rise. The scrip, however, outperformed the market in past one quarter, gaining 4.98% as against Sensex's 4.45% rise.
</p>
<p>
The large-cap company has an equity capital of Rs 207.12 crore. Face value per share is Re 1. 
</p>
<p>
As per reports, the US Food and Drug Administration (USFDA) has imposed a ban on imports from <a class="storyTags" href="/search?type=news&amp;q=sun+pharmaceutical" target="_blank">Sun Pharmaceutical </a>Industries's plant at Karkhadi in <a class="storyTags" href="/search?type=news&amp;q=gujarat" target="_blank">Gujarat.</a> The Karkhadi plant makes both drug ingredients and formulations. The USFDA's "import alert" was announced on Wednesday, 12 March 2014. According to the FDA, an "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices. 
</p>
<p>
<a class="storyTags" href="/search?type=news&amp;q=sun+pharmaceutical" target="_blank">Sun Pharmaceutical </a>Industries' consolidated net profit surged 73.73% to Rs 1531.09 crore on 51.59% increase in total income to Rs 4446.82 crore in Q3 December 2013 over Q3 December 2012.
</p>
<p>
Sun Pharmaceutical Industries is an international specialty pharmaceutical company with over 72% sales from global markets. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in US, India and several other markets across the world.
</p>
<p><b><i>Powered by</i> Capital Market - Live News</b></p>
<p>PREVIOUS STORY</p>
<p>NEXT STORY</p>
<p>Copyrights © 2018 Business Standard Private Ltd. All rights reserved.</p>
<p style="padding:10px;"><img alt="Business Standard" src="https://bsmedia.business-standard.com/include/_mod/site/html5/images/business-standard-logo.png" title="Business Standard"/></p>
<p style="padding:10px;"><span class="fsubs_country_p2"><strong>Upgrade To Premium Services</strong></span></p>
<p class="fsubs_country_p2"> Business Standard is happy to inform you of the launch of "Business Standard Premium Services"</p>
<p class="fsubs_country_p2">As a premium subscriber you get an across device unfettered access to a range of services which include:</p>
<p style="padding:10px;"><img alt="Business Standard" src="https://bsmedia.business-standard.com/include/_mod/site/html5/images/business-standard-logo.png" title="Business Standard"/></p>
<p><span class="fsubs_country_p2" style="line-height:18px;"><strong>Premium Services </strong></span></p>
<p><span class="fsubs_country_p2" style="line-height:18px;"><strong>In Partnership with <img alt="Fis Logo" src="https://bsmedia.business-standard.com/include/_mod/site/html5/images/fis-logo-130x58.png" style="vertical-align:bottom;"/></strong></span></p>
<p class="fsubs_country_p2"><strong>Dear <span id="fis-username-popup">Guest</span>,</strong></p>
<p class="fsubs_country_p2">Welcome to the premium services of Business Standard brought to you courtesy FIS.<br/>
         Kindly visit the <span class="chk"><a href="/subscription-cart/manage">Manage my subscription page</a></span> to discover the benefits of this programme.<br/>
<br/>
         Enjoy Reading!<br/>
         Team Business Standard
      </p>
